Prevalence of Shigella serogroups and their antimicrobial resistance patterns in Southern Trinidad

Journal of Health, Population and Nutrition

Volumn 26, Issue 4, 2008, Pages 456-462

  Orrett, Fitzroy A ^a  

^a UNIVERSITY OF THE WEST INDIES   (Trinidad and Tobago)

Author keywords

Antibiotics; Bacillary; Community based studies; Drug resistance; Dysentary; Microbial; Shigella; Trinidad and Tobago

Indexed keywords

SHIGELLA; SHIGELLA BOYDII; SHIGELLA DYSENTERIAE; SHIGELLA FLEXNERI; SHIGELLA SONNEI;

ANTIINFECTIVE AGENT;

ACUTE DISEASE; ANTIBIOTIC RESISTANCE; ARTICLE; CHILD; DIARRHEA; FECES; HOSPITALIZATION; HUMAN; INFANT; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; NEWBORN; PRESCHOOL CHILD; PREVALENCE; SHIGELLA; SHIGELLOSIS; TRINIDAD AND TOBAGO;

ACUTE DISEASE; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DIARRHEA; DRUG RESISTANCE, BACTERIAL; DYSENTERY, BACILLARY; FECES; HUMANS; INFANT; INFANT, NEWBORN; MICROBIAL SENSITIVITY TESTS; PREVALENCE; SEVERITY OF ILLNESS INDEX; SHIGELLA; TRINIDAD AND TOBAGO;

EID: 59449091049     PISSN: 16060997     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Bennish ML, Wojtyniak BJ. Mortality due to shigellosis: community and hospital data. Rev Infect Dis 1991;13(Suppl 4):S245-51.
2. Jousilahti P, Madkour SM, Lambrechts T, Sherwin E. Diarrhoeal disease morbidity and home treatment practices in Egypt. Public Health 1997;111:5-10.
3. Lee H, Kotloff K, Chukaserm P, Samosornsuk S, Chompook P, Deen JL et al. Shigellosis remains an important problem in children less than 5 years of age in Thailand. Epidemiol Infect 2005;133:469-74.
4. Sur D, Ramamurthy T, Deen J, Bhattacharya SK. Shigellosis: challenges and management issues. Indian J Med Res 2004;120:454-62.
5. Thong KL, Hoe CH, Koh YT, Yasim RM. Prevalence of multidrug-resistant Shigella isolated in Malaysia. J Health Popul Nutr 2002;20:356-8.
6. Subekti D, Oyofo BA, Tjaniadi P, Corwin AL, Larasati W, Putri M et al. Shigella spp. surveillance in Indonesia: the emergence or reemergence of S. dysenteriae. Emerg Infect Dis 2001;7:137-40.
7. Orrett FA. Drug resistance and plasmid profile of Shigella organisms from different outbreaks in Trinidad and Tobago in 1994. East Afr Med J 1997;74:143-6.
8. Niyogi SK. Shigellosis. J Microbiol 2005;43:133-43.
9. World Health Organization. Diarrhoeal disease due to Shigella disease. In: Vaccines, immunization and biologicals. Geneva: World Health Organization, 1998:1-5.
10. Pelczar MJ, Jr., Chan ECS, editors. Elements of microbiology. Tokyo: Kogakusha-McGraw Hill, 1981:494-507.
11. Sivapalasingam S, Nelson JM, Joyce K, Hoekstra M, Angulo FJ, Mintz ED. High prevalence of antimicrobial resistance among Shigella isolates in the United States tested by the National Antimicrobial Resistance Monitoring System from 1999 to 2002. Antimicrob Agents Chemother 2006;50:49-54.
12. Preston MA, Brown S, Borczyk A. Multiple-resistant Shigella sonnei from recent outbreaks in Canada. Can Dis Wkly Rep 1991;17:277-9.
13. Zafar A, Sabir N, Bhutta ZA. Frequency of isolation of Shigella serogroups/serotypes and their antimicrobial susceptibility pattern in children from slum areas in Karachi. J Pak Med Assoc 2005; 55:184-8.
14. Geldreich EE, Bordner RH. Faecal contamination of fruits and vegetables during cultivation and processing for marketing: a review. J Milk Food Technol 1971;34:184-95.
15. Taylor BC, Nakamura M. Survival of Shigellae in food. J Hyg (Lond) 1964;62:303-11.
16. World Health Organization. Programme for Control of Diarrhoeal Diseases. Guidelines for the control of epidemics due to S. dysenteriae 1. Geneva: World Health Organization, 1988:1-15.
17. Mata LJ, Gangarosa EJ Cáceres A, Perera DR, Mejicanos ML. Epidemic Shiga bacillus dysentery in Central America. 1. Etiologic investigations in Guatemala, 1969. J Infect Dis 1970;122:170-80.
18. Ahmed K, Shakoori FR, Shakoori AR. Aetiology of shigellosis in northern Pakistan. J Health Popul Nutr 2003;21:32-9.
19. Bogaerts J, Verhaegen J, Munyabikali JP, Mukantabana B, Lemmens P, Vandeven J. Antimicrobial resistance and serotypes of Shigella isolates in Kigali, Rwanda (1983 to 1993): increased frequency of multiple resistance. Diagn Microbiol Infect Dis 1997;28:165-71.
20. Keusch GI, Thea DM. Invasion and tissue-damaging enteric bacterial pathogens causing bloody diarrhoea and dysentery. In: Schaechter M, Medoff G, Eisenstein BI, editors. Mechanism of microbial diseases. Baltimore, MD: Williams and Walkins, 1993:267-8.
21. DeRoeck D, Clemens JD, Nyamete A, Mahoney RT. Policymakers' views regarding the introduction of new-generation vaccines against typhoid fever, shigellosis and cholera in Asia. Vaccine 2005;23:2762-74.
22. Lin SR, Chang SF. Drug resistance and plasmid profile of Shigellae in Taiwan. Epidemiol Infect 1992;108:87-97.
23. Shahid NS, Rahaman MM, Haider K, Banu H, Rahman N. Changing pattern of resistant Shiga bacillus (Shigella dysenteriae type 1) and Shigella flexneri in Bangladesh. J Infect Dis 1985; 152:1114-19.
24. Wilson G, Easow JM, Mukhopadhyay C, Shivananda PG. Isolation and antimicrobial susceptibility of Shigella from patients with acute gastroenteritis in Western Nepal. Indian J Med Res 2006; 123:145-50.
25. Cheasty T, Skinner JA, Rowe B, Threlfall EJ. Increasing incidence of antibiotic resistance in Shigellae from humans in England and Wales: recommendations for therapy. Microb Drug Resist 1998;4:57-60.
26. Essers B, Burnens AP, Lanfranchini FM, Somaruga SG, von Vigier RO, Schaad UB et al. Acute community-acquired diarrhea requiring hospital admission in Swiss children. Clin Infect Dis 2000;31:192-6.
27. Heikkilä E, Siitonen A, Jahkola M, Fling M, Sundström L, Huovinen P. Increase of trimethoprim resistance among Shigella species, 1975-1988: analysis of resistance mechanisms. J Infect Dis 1990;161:1242-8.
28. Lima AA, Lima NL, Pinho MCN, Barros Juñior EA, Teixeira MJ, Martins MCV et al. High frequency of strains multiply resistant to ampicillin, trimethoprim-sulfamethoxazole, streptomycin, chloramphenicol, and tetracycline isolated from patients with shigellosis in northeastern Brazil during the period 1988 to 1993. Antimicrob Agents Chemother 1995;39:256-9.
29. Torres ME, Pírez MC, Schelotto F, Varela G, Parodi V, Allende F et al. Etiology of children's diarrhea in Montevideo, Uruguay: associated pathogens and unusual isolates. J Clin Microbiol 2001;39:2134-9.
30. Wikler MA, Cockerill FR, Craig WA, Dudley MN, Eliopoulos GM, Hecht DW et al. Performance standards for antimicrobial disk susceptibility testing. Approved standards. 9th ed. V. 26 (1). Wayne, PA: Clinical and Laboratory Standards Institute, 2006:M2-A9.
31. Ashkenazi S, May-Zahav M, Sulkes J, Zilberberg R, Samra Z. Increasing antimicrobial resistance of Shigella isolates in Israel during the period 1984 to 1992. Antimicrob Agents Chemother 1995;39:819-23.
32. Bhattacharya S, Khanal B, Bhattarai NR, Das ML. Prevalence of Shigella species and their antimicrobial resistance patterns in eastern Nepal. J Health Popul Nutr 2005;23:339-42.
33. Opintan JA, Newman MJ. Distribution of serogroups and serotypes of multiple drug resistant Shigella isolates. Ghana Med J 2007;41:8-29.
34. Legros D, Ochola D, Lwanga N, Guma G. Antibiotic sensitivity of endemic Shigella in Mbarara, Uganda. East Afr Med J 1998;75:160-1.
35. Mache A. Antimicrobial resistance and serogroups of Shigella among paediatric outpatients in southwest Ethiopia. East Afr Med J 2001;78:296-9.
36. Keusch GT, Bennish ML. Shigellosis. In: Evans AS, Brachman PS, editors. Bacterial infections of humans: epidemiology and control. 2nd ed. New York, NY: Plenum, 1991:593-620.
37. Hossain MA, Albert MJ, Hasan KZ. Epidemiology of shigellosis in Teknaf, a coastal area of Bangladesh: a 10-year survey. Epidemiol Infect 1990;105:41-9.
38. Tjaniadi P, Lesmana M, Subekti D, Machpud N, Komalarini S, Santoso W, et al. Antimicrobial resistance of bacterial pathogens associated with diarrheal patients in Indonesia. Am J Trop Med Hyg 2003;68:666-70.
39. Al-Moyed KA, Harmal NS, Al-Harasy AH, Al-Shamahy HA. Increasing single and multi-antibiotic resistance in Shigella species isolated from shigellosis in Sana'a, Yemen. Saudi Med J 2006;27:1157-60.
40. Jain SK, Gupta A, Glanz B, Dick J, Siberry GK. Antimicrobial-resistant Shigella sonnei: limited antimicrobial treatment options for children and challenges of interpreting in vitro azithromycin susceptibility. Pediatr Infect Dis J 2005;24:494-7.
41. Khan-Mohammed Z, Adesiyun AA, Swanston WH, Chadee DD. Frequency and characteristics of selected enteropathogens in fecal and rectal specimens from childhood diarrhea in Trinidad, 1998-2000. Rev Panam Salud Publica 2005;17:170-7.
42. Ghosh AR, Sehgal SC. Shigella infections among children in Andaman: an archipelago of tropical islands in Bay of Bengal. Epidemiol Infect 1998;121:43-8.
43. Orrett FA, Shurland SM. Prevalence of bacterial pathogens and susceptibility patterns from clinical sources in Trinidad. West Indian Med J 2000;49:205-09.
44. Orrett FA, Shurland SM. Susceptibility patterns and serotypes of non-typhoidal Salmonella in Trinidad. Saudi Med J 2001;21:852-55.
45. Orrett FA. Antimicrobial susceptibility patterns of urinary pathogens in Trinidad, 1996-1999. J Natl Med Assoc 2003;95:352-62.
46. Watanabe T. Infective heredity of multiple drug resistance in bacteria. Bacteriol Rev 1963;27:87-115.
47. Fontaine O. Antibiotics in the management of shigellosis in children: what role for quinolones? Rev Infect Dis 1989;11(Suppl):S1145-50.
48. Hampel B, Hullmann R, Schmidt H. Ciprofloxacin in pediatrics: worldwide clinical experience based on compassionate use - safety report. Pediatr Infect Dis J 1997;16:127-9.